Vermont Center on Behavior and Health investigators were notified that they received a $5.5 million, five-year grant to participate in the Phase II portion of the HEALthy Brain and Child Development (HBCD) Study,
In November 2021, Vermont Center on Behavior and Health investigators were notified that they received a $5.5 million, five-year grant to participate in the Phase II portion of the HEALthy Brain and Child Development (HBCD) Study, an initiative focused on gathering data on brain development from birth through early childhood.
Leading the UVM team are Alexandra Potter, Ph.D., and Hugh Garavan, Ph.D. Both professors are involved in the Consortium Administrative Core for the study and are co-lead investigators on the ABCD study. Sarah Heil, PhD, also a co-investigator, will lead the recruitment efforts for the UVM site of HBCD, with particular focus on substance using pregnant women. She will provide direct supervision to the recruitment specialist, and will collaborate on scientific products
The HBCD study complements the landmark Adolescent Brain Cognitive Development (ABCD) Study launched in 2015 – a longitudinal study tracking nearly 12,000 youth from age 10 through to young adulthood using advanced neuroimaging to observe brain development and has many of the same data collection elements as HBCD.
The goal of the HBCD study is to provide a template of normative neurodevelopment and help identify factors that influence development, eventually leading to greater risk or resilience for numerous mental health and neurocognitive outcomes. Sites will enroll 7,500 pregnant women in their second trimester and will follow them and their children for up to 10 years, collecting data on pregnancy and fetal development; infant and early childhood structural and functional brain imaging; brain size and physical characteristics; medical history; family history; biological specimens; and social, emotional and cognitive development.
Read more